U.S. Clinical Trial Supplies Market Size & Outlook
U.S. clinical trial supplies market, 2018-2030 (US$M)
Related Markets
U.S. clinical trial supplies market highlights
- The U.S. clinical trial supplies market generated a revenue of USD 1,357.1 million in 2023 and is expected to reach USD 2,105.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Clinical trial supplies market data book summary
| Market revenue in 2023 | USD 1,357.1 million |
| Market revenue in 2030 | USD 2,105.8 million |
| Growth rate | 6.5% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III |
| Key market players worldwide | Almac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair |
Other key industry trends
- In terms of revenue, U.S. accounted for 52.6% of the global clinical trial supplies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. clinical trial supplies market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 2,105.8 million by 2030.
Phase iii was the largest segment with a revenue share of 52.04% in 2023. Horizon Databook has segmented the U.S. clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. clinical trial supplies market is anticipated to witness significant growth rate over the forecast period. Around 45.9% of the clinical trials registered are in the U.S., as per Almac’s annual report of 2016, and it is a major reason for growth of this market over the years.
The demand for reducing R&D cost is changing the preference to emerging countries, thereby increasing the demand for cost-effective supplies, which is anticipated to contribute to the growth of clinical trial supplies market in the U.S.
The trend of shifting clinical trials sites outside the U.S is expected to continue due to rising cost of R&D & patient recruitment in the country and less disease variation among the population. Majority of the top players are located in the U.S. and the region is expected to witness innovations in clinical trial supplies.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supplies Market Scope
Clinical Trial Supplies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. clinical trial supplies market size, by phase, 2018-2030 (US$M)
U.S. Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
